Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 5Tumor-Agnostic 2Gynecologic 1Breast 1

Conditions

Carcinoma, Squamous Cell 2Carcinoma 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × calcipotriene × Tumor-Agnostic × Clear all
NCT03370406 2026-06-01

Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC

University of Pittsburgh

Phase 1 Recruiting
30 enrolled
Tumor-Agnostic

Carcinoma, Carcinoma, Squamous Cell

NCT04839731 2023-02-13

Combination 5-FU / Calcipotriene Cream for SCCIS/SCC

Carilion Clinic

Phase EARLY_PHASE1 Unknown
30 enrolled
Tumor-Agnostic

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡